Gries Financial »

Alnylam Pharmaceuticals shares owned by Gries Financial

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Gries Financial from 13F filings

Historical chart of Gries Financial investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Gries Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Gries Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $229k 502 456.00

More positions owned by Gries Financial

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (GAUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
RBB Us Treas 3 Mnth (TBIL)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Ishares Tr U.s. Tech Etf (IYW)
Apple (AAPL)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr 10-20 Yr Trs Etf (TLH)

View all positions for Gries Financial

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals